Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional Results available

A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Esophagitis

ClinicalTrials.gov ID: NCT04322708

Public ClinicalTrials.gov record NCT04322708. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 27, 2026, 1:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lirentelimab (AK002) in Adult and Adolescent Patients With Active Eosinophilic Esophagitis

Study identification

NCT ID
NCT04322708
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Allakos Inc.
Industry
Enrollment
277 participants

Conditions and interventions

Interventions

  • Placebo Other
  • lirentelimab (AK002) Drug

Other · Drug

Eligibility (public fields only)

Age range
12 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 5, 2020
Primary completion
Jun 3, 2021
Completion
Jan 17, 2022
Last update posted
Jan 1, 2024

2020 – 2022

United States locations

U.S. sites
73
U.S. states
29
U.S. cities
65
Facility City State ZIP Site status
Allakos Investigational Site Birmingham Alabama 35209
Allakos Investigational Site Huntsville Alabama 38801
Allakos Investigational Site Gilbert Arizona 85234
Allakos Investigational Site Phoenix Arizona 85016
Allakos Investigational Site Phoenix Arizona 85021
Allakos Investigational Site Scottsdale Arizona 85251
Allakos Investigational Site Little Rock Arkansas 72205
Allakos Investigational Site La Jolla California 92037
Allakos Investigational Site Los Angeles California 90025
Allakos Investigational Site Oakland California 94612
Allakos Investigational Site Santa Monica California 90404
Allakos Investigational Site Tustin California 92780
Allakos Investigational Site Ventura California 93003
Allakos Investigational Site Walnut Creek California 94598
Allakos Investigational Site Aurora Colorado 80045
Allakos Investigational Site Centennial Colorado 80112
Allakos Investigational Site Brandon Florida 33511
Allakos Investigational Site Edgewater Florida 32132
Allakos Investigational Site Jacksonville Florida 32256
Allakos Investigational Site Miami Florida 33176
Allakos Investigational Site Orlando Florida 32803
Allakos Investigational Site Orlando Florida 32806
Allakos Investigational Site Tampa Florida 33603
Allakos Investigational Site Tampa Florida 33615
Allakos Investigational Site Atlanta Georgia 30342
Allakos Investigational Site Columbus Georgia 31904
Allakos Investigational Site Chicago Illinois 60611
Allakos Investigational Site Indianapolis Indiana 46202
Allakos Investigational Site Iowa City Iowa 52242
Allakos Investigational Site Lexington Kentucky 40503
Allakos Investigational Site Crowley Louisiana 70526
Allakos Investigational Site Chevy Chase Maryland 20815
Allakos Investigational Site Boston Massachusetts 02111
Allakos Investigational Site Boston Massachusetts 02115
Allakos Investigational Site Boston Massachusetts 02215
Allakos Investigational Site Ann Arbor Michigan 48109
Allakos Investigational Site Troy Michigan 48098
Allakos Investigational Site Kansas City Missouri 64108
Allakos Investigational Site Kalispell Montana 59901
Allakos Investigational Site Las Vegas Nevada 89106
Allakos Investigational Site Reno Nevada 89511
Allakos Investigational Site Great Neck New York 11021
Allakos Investigational Site New York New York 10029
Allakos Investigational Site Asheville North Carolina 28801
Allakos Investigational Site Chapel Hill North Carolina 27599
Allakos Investigational Site Charlotte North Carolina 28210
Allakos Investigational Site Charlotte North Carolina 28277
Allakos Investigational Site Durham North Carolina 27710
Allakos Investigational Site High Point North Carolina 27262
Allakos Investigational Site Rocky Mount North Carolina 27804
Allakos Investigational Site Akron Ohio 44302
Allakos Investigational Site Cincinnati Ohio 45229
Allakos Investigational Site Cincinnati Ohio 45231
Allakos Investigational Site Cleveland Ohio 44106
Allakos Investigational Site Dayton Ohio 45415
Allakos Investigational Site Mentor Ohio 44060
Allakos Investigational Site Oklahoma City Oklahoma 73112
Allakos Investigational Site Danville Pennsylvania 17822
Allakos Investigational Site Philadelphia Pennsylvania 19104
Allakos Investigational Site Greenville South Carolina 29615
Allakos Investigational Site Chattanooga Tennessee 37421
Allakos Investigational Site Hixson Tennessee 37343
Allakos Investigational Site Nashville Tennessee 37212
Allakos Investigational Site Austin Texas 78704
Allakos Investigational Site Garland Texas 75044
Allakos Investigational Site San Antonio Texas 78229
Allakos Investigational Site Ogden Utah 84405
Allakos Investigational Site Riverton Utah 84065
Allakos Investigational Site Salt Lake City Utah 84132
Allakos Investigational Site Sandy City Utah 84092
Allakos Investigational Site Leesburg Virginia 20176
Allakos Investigational Site Seattle Washington 98105
Allakos Investigational Site Seattle Washington 98115

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04322708, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 1, 2024 · Synced Jun 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04322708 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →